Fapon Biotech

Private

DongguanHealthcare & Life Scienceshttps://www.faponbiotech.com/

Last Round

IPO Announced

Feb 1, 2024

Est. Valuation

$3.86B

Company Overview

Fapon Biotech is a biotechnology company that provides in vitro diagnostic (IVD) raw materials, reagent services, and open-system instrument platforms for the global diagnostics industry.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Data as a Service

AI Layer

Application

Keywords

in-vitro diagnosticIVDdiagnostic raw materialsantibodiesantigensdiagnostic reagentsdiagnostic platformCDMOmolecular diagnosticsbiotech supply chainCLIA analyzerreagent manufacturingbiotech R&Dlife science toolsassay development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fapon Biotech Comps

Public and private peers based on sector, stage, and business model.

Fapon Biotech comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Fapon Biotech Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
IPO Announced	Feb 1, 2024
Series B	Dec 1, 2020
Private Equity	Jan 1, 2019
Private Placement	May 1, 2017
Private Placement	Aug 1, 2016

View all Funding Rounds

Key People

Founding team and executive leadership

Paul Lundquist

Chief Technology Officer, Sequencing

Executive Team

Fapon Biotech Investors

Notable investors and investment history

Fapon Biotech investors
Investor	Rounds
Cathay Capital	Series B
GL Capital Group	Series B
Dingfeng Asset Management	Private Placement
明道投资	Private Placement
CPE	Series B

View all Investors

Fapon Biotech Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Fapon Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fapon Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersDongguan

Employee Range183

Year Founded2001

Last FundingFeb 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.